Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
Malignant Phosphaturic Mesenchymal Tumor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Conventional osteosarcoma is the most common primary malignancy of bone. This group of neoplasms is subclassified according to… Expand
2017
2017
Rationale: Phosphaturic mesenchymal tumor (PMT) is a new tumor entity of soft tissue and bone tumor recently accepted by the… Expand
2017
2017
Key Messages: Octreotide can be used as an adjunctive therapy to increase phosphorus levels in patients with tumor-induced… Expand
2017
2014
2014
Tumor-induced osteomalacia (TIO) is a rare acquired form of hypophosphatemia commonly associated with phosphaturic mesenchymal… Expand
2011
2011
Phosphaturic mesenchymal tumors are rare neoplasms predominantly originating in the trunk and extremities. Malignant variants are… Expand
Review
2011
Highly Cited
2009
Highly Cited
2009
The majority of the oncogenic osteomalacia-associated mesenchymal tumors are considered to belong to the category of phosphaturic… Expand
Highly Cited
2001
Highly Cited
2001
Abstract Phosphaturic mesenchymal tumor is a rare neoplasm which causes osteomalacia or rickets. The tumor typically follows a… Expand
